ABBAS, A. K., A. H. LICHTMAN u. J. S. POBER (1996):
Immunologie.
Verlag Huber, Bern, S. 238-242, 305-308
ABE, J., B. L. KOTZIN, K. JUJO, M. E. MELISH, M. P. GLODE, T. KOHSAKA u. D. Y.
LEUNG (1992):
Selective expansion of T cells expressing T-cell receptor variable regions Vbeta 2 and Vbeta 2 in Kawasaki disease.
Proc. Natl. Acad. Sci. USA 89, 4066-4070
ABE, J., B. L. KOTZIN, C. MEISSNER, M. E. MELISH, M. TAKAHASHI, D. FULTON, F.
ROMAGNE, B. MALISSEN u. D. Y. LEUNG (1993):
Characterization of T-cell repertoire changes in acute Kawasaki disease.
J. Exp. Med. 177, 791-796
AFRAKHTE, M., A. MOREN, S. JOSSAN, S. ITOH, K. SAMPATH, B. WESTERMARK, C. H.
HELDIN u. P. TEN DIJKE (1998):
Induction of inhibitory Smad 6 and Smad 7 mRNS by TGF-beta family members.
Biochem. Biophys. Res. Commun. 249, 505-511 ALEVIZOPOULOS, A., u. N. MERMOD (1997):
Transforming growth factor-β: the breaking open of a black box.
Bioessays 19, 581-591
AMMANN, A. J., u. H. H. FUDENBERG (1982):
Immunodeficiency diseases.
in: D. P. STITES, J. D. STOBO, H. H. FUDENBERG u. J. V. WELLS (Hrsg.): Basic and clinical immunology.
4. Aufl. Verlag Lange Medical Publications, Los Altos, Kalifornien, S. 395-429 AVRAMEAS, S., u. B. GUILBERT (1971a):
Dosage enzymoimmunologique de protéines à l’aide d’immunoadsorbants et d’antigènes marqués aux enzymes.
C. R. Acad. Sci. (Paris) 273, 2705-2707
BANG, Y.-J., S.-J. KIM, D. DANIELPOUR, M. A. O’REILLY, K. Y. KIM, C. E. MYERS u. J. B.
TREPEL (1992):
Cyclic AMP induces Transforming growth factor-β2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3.
Proc. Natl. Acad. Sci. USA 89, 3556-3560
BARNARD, J. A., R. M. LYONS u. H. L. MOSES (1990):
The cell biology of Transforming growth factor β.
Biochem. Biophys. Acta 1032, 79-87
BEALE, M. G., G. S. NASH, M. J. BERTOVICH u. R. P. MAC DERMOTT (1982):
Similar disturbances in B cell activity and regulatory T cell function in Henoch-Schönlein purpura and systemic lupus erythematosus.
J. Immunol. 128, 486-491
BEALE, M. G., G. S. NASH, M. J. BERTOVICH u. R. P. MAC DERMOTT (1983):
Evidence of enhanced immunoglobulin synthesis and defective immune regulation in Henoch-Schönlein purpura.
Contrib. Nephrol. 35, 46-60
BECK, L. S., L. DEGUZMAN, W. P. LEE, Y. XU, L. A. MC FATRIDGE u. E. P. AMENTO (1991):
TGF-β1 accelerates wound healing: reversal of steroid-impaired healing in rats and rabbits.
Growth Factors 5, 295-304
BIDWELL, D. E., A. A. BUCK, H. J. DIESFELD, B. ENDERS, J. HAWORTH, G. HULD, N. H.
KENT, C. KIRSTEN, P. MATTERN, E. J. RUITENBERG u. A. VOLLER (1976):
The enzyme-linked immunosorbent assay (ELISA).
Bull. Wld. Hlth. Org. 54, 129-139
BOGERS, W. M. J. M., R.-K. STAD, L. A. VAN ES u. M. R. DAHA (1991):
Immunglobulin A: Interaction with complement, phagocytic cells and endothelial cells.
Complement. Inflamm. 8, 347-358
BOUCHARD, G., H. PLATA-MADRID, R. S. YOUNGQUIST, G. M. BUENING, V. K.
GANJAM, G. F. KRAUSE, G. K. ALLEN u. A. L. PAINE (1992):
Absorption of an alternate source of immunoglobulin in pups.
Am. J. Vet. Res. 53, 230-233
BRATTSAND, R., u. M. LINDEN (1996):
Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies.
Aliment. Pharmacol. Ther. 10, 81-91
BRODIN, G., A. AHGREN, P. TEN DIJKE, C. H. HELDIN u. R. HEUCHEL (2000):
Efficient TGF-beta induction of the Smad 7 gen requires cooperation between AP-1, Sp1, and Smad proteins on the mouse Smad 7 promoter.
J. Biol. Chem. 15, 29023-29030
BROOKS, P. N. (1984):
Necrotizing vasculitis in a group of Beagles.
Lab. Animals 18, 285-290
BUDKA, H., H. BERNHEIMER, J. J. HAAIJMAN u. J. RADL (1985):
Occurrence of IgA subclasses (IgA1 and IgA2) in the human nervous system. Correlation with disease.
Int. Archs. Allergy appl. Immun. 76, 107-115
BURGENER, I., L. VAN HAM, A. JAGGY, M. VANDEVELDE u. A. TIPOLD (1998):
Chemotactic activity and IL-8 levels in the cerebrospinal fluid in canine steroid responsive meningitis-arteriitis.
J. Neuroimmun. 89, 182-190
BURNS, J. C., P. J. FELSBURG, H. WILSON, F. S. ROSEN u. L. T. GLICKMAN (1991):
Canine pain syndrome is a model for the study of Kawasaki disease.
Perspect. Biol. Med. 35, 68-73
CAGNOLI, L., E. BELTRENDI, S. PASQUALI, R. BIAGI, M. CASADEI-MALDINI, L. ROSSI u. P. ZUCCHELLI (1985):
B and T cells abnormalities in patients with primary IgA nephropathy.
Kidney Int. 28, 646-651
CASANUEVA, B., V. RODRIGUEZ-VALVERDE, M. C. FARIŃAS, A. VALLO u. J.
RODRIGUEZ-SORIANO (1990):
Autologous mixed lymphocyte reaction and T-cell suppressor activity in patients with Henoch-Schönlein purpura and IgA nephropathy.
Nephron 54, 224-228
CEDERHOLM, B., T. LINNE, J. WIESLANDER, P. BYGREN u. D. HEINEGÅRD (1991):
Fibronectin-immunoglobulin complexes in the early course of IgA and Henoch-Schönlein nephritis.
Pediatr. Nephrol. 5, 200-204
CHAO, C. C., T. A. ALA, S. HU, K. B. CROSSLEY, R. E. SHERMAN, P. K. PETERSON u.
W. H. FREY II (1994):
Serum cytokine levels in patients with Alzheimer’s disease.
Clin. Diagn. Lab. Immunol. 1, 433-436 CHRISMAN, C. L. (1992):
Cerebrospinal fluid analysis.
Vet. Clin. North Am. Small Anim. Pract. 22, 781-810
CIZINAUSKAS, S., A. JAGGY u. A. TIPOLD (2000):
Long-term treatment of dogs with steroid-responsive meningitis-arteriitis: Clinical, laboratory and therapeutic results.
J. Small Anim. Pract. 41, 295-301 COHN, L. A. (1997):
Glucocorticoids as immunsuppressive agents.
Semin. Vet. Med. Surg. (Small Anim.) 12, 150-156 COFFMAN, R. L., u. M. COHN (1977):
The class of surface immunoglobulin on virgin and memory B-lymphocytes.
J. Immunol. 118, 1806-1815
COFFREY, R. J., W. E. RUSSELL u. J. A. BARNARD (1990):
Pharmacokinetic of TGF-β with emphasis on effects in liver and gut.
Ann. N. Y. Acad. Sci. 593, 285-291
COLLETTA, A. A., L. M. WAKEFIELD, F. V. HOWELL, D. DANIELPOUR, M. BAUM u. M. B.
SPORN (1991):
The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of Transforming growth factor beta.
J. Clin. Invest. 87, 277-283
CONSTAM, D. B., J. PHILIPP, U. V. MALIPIERO, P. TEN DIJKE, M. SCHACHNER u. A.
FONTANA (1992):
Differential expression of Transforming growth factor-β1, -β2 and -β3 by glioblastoma cells, astrocytes, and microglia.
J. Immunol. 148, 1404-1410
COPPO, R., B. BASOLO, G. MARTINA, C. ROLLINO, M. DE MARCHI, F. GIACCHINO, G.
MAZZUCCO, M. MESSINA u. G. PICCOLI (1982):
Circulating immune complexes containing IgA, IgG and IgM in patients with primary IgA nephropathy and with Henoch-Schoenlein nephritis. Correlation with clinical and histologic signs of activity.
Clin. Nephrol. 18, 230-239
COX, D. A., u. T. MAURER (1997):
Transforming growth factor-β.
Clin. Immunol. Immunopathol. 83, 25-30
DA CUNHA, A., J. A. JEFFERSON, R. W. JACKSON u. L. VITKOVIC (1993):
Glial cell-specific mechanisms of TGF-β1 induction by IL-1 in cerebral cortex.
J. Neuroimmunol. 42, 71-86 DANIELPOUR, D. (1993):
Improved sandwich enzyme-linked immunosorbent assays for Transforming growth factor-β1.
J. Immunol. Methods 158, 17-25
DANIELPOUR, D., L. L. DART, K. C. FLANDERS, A. B. ROBERTS u. M. B. SPORN (1989a):
Immunodetection and quantitation of the two forms of Transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture.
J. Cell Physiol. 138, 79-86
DANIELPOUR, D., K. Y. KIM, L. L. DART, S. WATANABE, A. B. ROBERTS u. M. B.
SPORN (1989b):
Sandwich enzyme-linked immunosorbent assays (S-ELISAs) quantitate and distinguish two forms of Transforming growth factor (TGF-beta 1 and TGF-beta 2) in complex biological fluids.
Growth Factors 2, 61-71
DANIELPOUR, D., K. Y. KIM, L. L. DART, S. WATANABE, A. B. ROBERTS u. M. B.
SPORN (1990):
Evidence for differential regulation of TGF-β1 and TGF-β2 expression in vivo by sandwich enzyme-linked immunosorbent assays.
Ann. N. Y. Acad. Sci. 593, 300-302
DANIELPOUR, D., K. Y. KIM, T. S. WINOKUR u. M. B. SPORN (1991):
Differential regulation of the expression of Transforming growth-factor-βs 1 and 2 by retinoic acid, epidermal growth factor and dexamethasone in NRK-49F and A549 cells.
J. Cell. Physiol. 148, 235-244
DASCH, J. R., D. R. PACE, W. O. WAEGELL, D. INENAGA u. L. E. ELLINGSWORTH (1989):
Monoclonal antibodies recognising Transforming growth factor-beta. Bioactivity neutralisation and Transforming growth factor beta 2 affinity purification.
J. Immunol. 142, 1536-1541
DASCH, J. R., W. O. WAEGELL, K. CARROLL, D. R. PACE u. L. E. ELLINGSWORTH (1990):
Capture immunoassays specific for TGF-β1 and TGF-β2 use in pharmacokinetic studies.
Ann. N. Y. Acad. Sci. 593, 303-305 DAY, M. J., u. W. J. PENHALE (1988):
Serum immunoglobulin A concentrations in normal and diseased dogs.
Res. Vet. Sci. 45, 360-363
DE GROOT, C. J., L. MONTAGNE, A. D. BARTEN, P. SMINIA u. P. VAN DER VALK (1999):
Expression of Transforming growth factor (TGF)-beta 1, -beta 2, and –beta 3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.
J. Neuropathol. Exp. Neurol. 58, 174-187 DE LAHUNTA, A. (1983):
Cerebrospinal fluid and hydrocephalus.
in: A. DE LAHUNTA (Hrsg.): Veterinary neuroanatomy and clinical neurology.
2. Aufl. Verlag Saunders Company, Philadelphia, London, S. 30-52 DERYNCK, R., u. X.-H. FENG (1997):
TGF-β receptor signaling.
Biochem. Biophys. Acta 1333, F105-F150
DOUGHERTY, S. A., S. A. CENTER, E. E. SHAW u. H. A. ERB (1991):
Juvenile-onset polyarthritis syndrome in Akitas.
JAVMA 198, 849-856
DUBOIS, C. M., M.-H. LAPRISE, F. BLANCHETTE u. L. E. GENTRY (1995):
Processing of Transforming growth factor β1 precursor by human furin convertase.
J. Biol. Chem. 270, 10618-10624
ENGVALL, E., u. P. PERLMANN (1971):
Enzyme-linked immunosorbent assay (ELISA). Quantitative assay for immunoglobulin G.
Immunochem. 8, 871-874
ERREN, M., H. REINECKE, R. JUNKER, M. FOBKER, H. SCHULTE, J. O. SCHUREK, J.
KROPF, S. KERBER, G. BREITHARDT, G. ASSMANN u. P. CULLEN (1999):
Systemic inflammatory parameters in patients with arteriosclerosis of the coronary and peripheral arteries.
Arterioscler. Thromb. Vasc. Biol. 19, 2355-2363
ESSER, C., u. A. RADBRUCH (1990):
Immunglobulin class switching: Molecular and cellular analysis.
Annu. Rev. Immunol. 8, 717-735
FANKHAUSER, R., u. M. VANDEVELDE (1979):
Liquoruntersuchung.
Kleintierpraxis 24, 211-216 FEEHALLY, J. (1988):
Immune mechanisms in glomerula IgA deposition.
Nephrol. Dial. Transplant. 3, 361-378
FELGENHAUER, K., u. H. J. SCHÄDLICH (1987):
The compartmental IgM and IgA response within the central nervous system.
J. Neurol. Sci. 77, 125-135 FELSBURG, P. J. (1998):
Immunoglobulins.
in: P.-P. PASTORET, P. GRIEBEL, H. BAZIN u. A. GOVAERTS (Hrsg.): Handbook of vertebrate immunology.
Academic Press, San Diego, London, S. 268-269
FELSBURG, P. J., L. T. GLICKMAN u. P. F. JEZYK (1985):
Selective IgA deficiency in the dog.
Clin. Immunol. Immunopathol. 36, 297-305
FELSBURG, P. J., H. HOGENESCH, R. L. SOMBERG, P. W. SNYDER u. L. T. GLICKMAN (1992):
Immunologic abnormalities in canine juvenile polyartritis syndrome: A naturally occurring animal model of Kawasaki disease.
Clin. Immunol. Immunopathol. 65, 110-118 FISHMAN, R. A. (1992):
Cerebrospinal fluid in diseases of the nervous system.
2. Aufl. Saunders Company, Philadelphia, London, S. 204/205
GINEL, P. J., M. NOVALES, M. D. LOZANO, J. M. MOLLEDA u. R. LOPEZ (1993a):
Local secretory IgA in dogs with low systemic IgA levels.
Vet. Rec. 132, 321-323
GINEL, P. J., M. NOVALES, M. GARCIA, E. M. MARTIN, R. LOPEZ u. J. M. MOLLEDA (1993b):
Immunoglobulins in stimulated tears of dogs.
Am. J. Vet. Res. 54, 1060-1063
GLICKMAN, L. T., F. S. SHOFER, A. J. PAYTON, L. L. LASTER u. P. J. FELSBURG (1988):
Survey of serum IgA, IgG and IgM concentrations in a large Beagle population in which IgA deficiency had been identified.
Am. J. Vet. Res. 49, 1240-1245
GRANGER, D., u. N. P. KUBES (1994):
The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion.
J. Leukoc. Biol. 55, 662-675
GRIOT-WENK, M. E., A. BUSATO, M. WELLE, B. P. RACINE, R. WEILENMANN, P. TSCHUDI u. A. TIPOLD (1999):
Total serum IgE and IgA antibody levels in healthy dogs of different breeds and exposed to different environments.
Res. Vet. Sci. 67, 239-243
HALE, G. M., S. L. MC INTOSH, Y. HIKI, A. R. CLARKSON u. A. J. WOODROFFE (1986):
Evidence for IgA-specific B cell hyperactivity in patients with IgA nephropathy.
Kidney Int. 29, 718-724 HARCOURT, R. A. (1978):
Polyarteritis in a colony of Beagles.
Vet. Rec. 102, 519-522
HARLING-BERG, C., P. M. KNOPF, J. MERRIAM u. H. F. CSERR (1989):
Role of cervical lymph nodes in the systemic humoral immune response to human serum albumin microinfused into rat cerebrospinal fluid.
J. Neuroimmunol. 25, 185-193
HAYES, T. J., G. K. S. ROBERTS u. W. H. HALLIWELL (1989):
An idiopathic febrile necrotizing arteritis syndrome in the dog: Beagle pain syndrome.
Toxicol. Pathol. 17, 129-137
HEINE, U. I., J. K. BURMESTER, K. C. FLANDERS, D. DANIELPOUR, E. F. MUNOZ, A. B.
ROBERTS u. M. B. SPORN (1991):
Localisation of Transforming growth factor-beta 1 in mitochondria of murine heart and liver.
Cell. Regul. 2, 467-477
HELDIN, C. H., K. MIYAZONO u. P. TEN DIJKE (1997):
TGF-β signalling from cell membrane to nucleus through SMAD proteins.
Nature 390, 465-471 HEREMANS, J. F. (1974):
Immunoglobulin A.
in: M. SELA (Hrsg.): The antigens.
Academic Press, New York, S. 365-522 HOGENESCH, H. (1998):
Mucosal immunity.
in: P.-P. PASTORET, P. GRIEBEL, H. BAZIN u. A. GOVAERTS (Hrsg.): Handbook of vertebrate immunology.
Academic Press, San Diego, London, S. 275-277
HUSBAND, A. J., D. R. KRAMER, S. BAO, R. M. SUTHERLAND u. K. W. BEAGLEY (1996):
Regulation of mucosal IgA responses in vivo: cytokines and adjuvants.
Vet. Immunol. Immunopathol. 54, 179-186
ICHIYAMA, T., T. HAYASHI, M. NISHIKAWA u. S. FURUKAWA (1997):
Levels of Transforming growth factor-β1, tumour necrosis factor-α, and interleukin-6 in cerebrospinal fluid: Association with clinical outcome for children with bacterial meningitis.
CID 25, 328-329
IRVING, G., u. C. CHRISMAN (1990):
Long-term outcome of five cases of corticosteroid-responsive meningomyelitis.
J. Am. Anim. Hosp. Assoc. 26, 324-328
ITOH, S., M. LANDSTROM, A. HERMANSSON, F. ITOH, C. H. HELDIN, N. E. HELDIN u.
P. TEN DIJKE (1998):
Transforming growth factor beta 1 induces nuclear export of inhibitory Smad 7.
J. Biol. Chem. 273, 195-201
JACOBSON, R. H., u. J. ROMATOWSKI (1996):
Assessing the validity of serodiagnostic test results.
Semin. Vet. Med. Surg. 11, 135-143
JOHNS, L. D., G. BABCOCK, D. GREEN, M. FREEDMAN, S. SRIRAM u. R. M.
RANSOHOFF (1992):
Transforming growth factor-β1 differentially regulates proliferation and MHC class-II antigen expression in forebrain and brainstem astrocyte primary cultures.
Brain Res. 585, 229-236
JOHNSON, M. D., C. F. FEDERSPIEL, L. I. GOLD u. H. L. MOSES (1992):
Transforming growth factor-β and Transforming growth factor-β-receptor expression in human meningioma cells.
Am. J. Pathol. 141, 633-642 JUNGI, T. W. (2000):
Antikörper.
in: T. W. JUNGI (Hrsg.): Klinische Veterinärimmunologie.
Verlag Enke, Stuttgart, S. 25-28
KÄLIN, S. P., P. ARNOLD, A. HAGEN, G. LOTT-STOLZ, U. NIEDERHAUSER u. P. RÜSCH (1987):
Sterile, eitrige Meningitis und generalisierte Vaskulitis, verursacht durch ein neues Medikament zur Nidationsverhütung beim Hund.
Schweiz. Arch. Tierheilk. 129, 335-342
KATAOKA, T., T. KAWAKAMI, N. TAKAHASHI u. T. HONJO (1980):
Rearrangement of immunoglobulin γ l-chain gene and mechanism for heavy-chain class switch.
Proc. Natl. Acad. Sci. USA 77, 919-923 KEMENY, D. M., u. S. CHANTLER (1988):
Introduction.
in: D. M. KEMENY u. S. J. CHALLACOMBE (Hrsg.): ELISA and other solid phase immunoassays. Theoretical and practical aspects.
Verlag Wiley, Chichester, New York, S. 1-2
KIEFER, R., T. SCHWEITZER, S. JUNG, K. V. TOYKA u. H. P. HARTUNG (1998):
Sequential expression of Transforming growth factor-beta 1 by T-cells, macrophages, and microglia in rat spinal cord during autoimmune inflammation.
J. Neuropathol. Exp. Neurol. 57, 385-395
KJELLMAN, C., S. P. OLOFSSON, O. HANSSON, T. VON SCHANTZ, M. LINDVALL, I.
NILSSON, L. G. SALFORD, H. O. SJOGREN u. B. WIDEGREN (2000):
Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma.
Int. J. Cancer 89, 251-258 KNIGHT, J. F. (1990):
The rheumatic poison: a survey of some published investigations of the immunopathogenesis of Henoch-Schönlein purpura.
Pediatr. Nephrol. 4, 533-541
KOBATAKE, K., Y. SHINOHARA u. S. YOSHIMURA (1980):
Immunoglobulins in cerebrospinal fluid.
J. Neurol. Sci. 47, 273-283 KREUTZBERG, G. W. (1995):
Microglia, the first line of defense in brain pathologies.
Arzneimittelforschung 45, 357-360
LACY, M. J., S. R. WHITTEMORE, D. L. HAVILAND, R. A. WETSEL u. S. R. BARNUM (1995):
Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia.
J. Neuroimmunol. 61, 71-78 LAPPIN, M. R. (2000):
ELISA tests: Methods and interpretation.
in: J. D. BONAGURA (Hrsg.): Kirk’s current veterinary therapie XIII. Small animal practice.
Verlag Saunders Company, Philadelphia, Pennsylvania, Bd. 13, S. 8-10 LAWRENCE, D. A. (1996):
Transforming growth factor-β: a general review.
Eur. Cytokine Netw. 7, 363-374 LIE, J. T. (1990):
Diagnostic histopathology of major systemic and pulmonary vasculitic syndromes.
Rheum. Dis. Clin. North Am. 16, 269-292
LINK, J., B. HE, V. NAVIKAS, W. PALASIK, S. FREDRIKSON, M. SODERSTROM u. H.
LINK (1995):
Transforming growth factor-β1 suppresses auto antigen-induced expression of pro-inflammatory cytokines but not of interleukin-10 in multiple sclerosis and myasthenia gravis.
J. Neuroimmunol. 58, 21-35
LOGAN, A., M. BERRY, A. M. GONZALEZ, S. A. FRAUTSCHY, M. B. SPORN u. A. BAIRD (1994):
Effects of Transforming growth factor-β1 on scar production in the injured central nervous system of the rat.
Eur. J. Neurosci. 6, 355-363
LÖSCHER, W., u. D. SCHWARTZ-PORSCHE (1986):
Low levels of γ-aminobutyric acid in cerebrospinal fluid of dogs with epilepsy.
J. Neurochem. 46, 1322-1325
LUCAS, C., L. N. BALD, B. M. FENDLY, M. MORA-WORMS, I. S. FIGARI, E. J. PATZER u.
M. A. PALLADINO (1990):
The autocrine production of Transforming growth factor-beta 1 during lymphocyte activation.
A study with a monoclonal antibody-based ELISA.
J. Immunol. 145, 1415-1422
LUND, E. M. u. J. S. KLAUSNER (1995):
Clinical epidemiology for the veterinary practitioner: The diagnostic process.
in: J. D. BONAGURA u. R. W. KIRK (Hrsg.): Kirk’s current veterinary therapie XII. Small animal practice.
Verlag Saunders Company, Philadelphia, Pennsylvania, Bd. 12, S. 7-11
MANNING, A. M., J. A. AUCHAMPACH, R. F. DRONG u. J. L. SLIGHTOM (1995):
Cloning of a canine cDNS homologous to the human Transforming growth factor-β1 – encoding gene.
Gene. 155, 307-308 MASSAGUÉ; J. (1990):
The Transforming growth factor-β family.
Ann. Rev. Cell. Biol. 6, 597-641
MASSAGUÉ; J., u. K. POLYAK (1995):
Mammalian antiproliferative signals and their targets.
Curr. Opinion Genet. Dev. 5, 91-96
MASSAGUÉ; J., L. ATTISANO u. J. L. WRANA (1994):
The TGF-β family and its composite receptors.
Trends Cell Biol. 4, 172-178
MASSAGUÉ; J., A. HATA u. F. LIU (1997):
TGF-β signalling through the Smad pathway.
Trends Cell Biol. 7, 187-192
MC TIGUE, D. M., P. G. POPOVICH, T. E. MORGAN u. B. T. STOKES (2000):
Localisation of Transforming growth factor-beta 1 and receptor mRNS after experimental spinal cord injury.
Exp. Neurol. 163, 220-230 MEAGER, A. (1991):
Assays for Transforming growth factor-β.
J. Immunol. Methods 141, 1-14
MELISH, M. E., u. R. V. HICKS (1990):
Kawasaki syndrome: Clinical features, pathophysiology, etiology and therapy.
J. Rheumatol. 17, 2-10
MERIC, S. M., V. PERMAN u. R. M. HARDY (1985):
Corticosteroid-responsive meningitis in ten dogs.
J. Am. Anim. Hosp. Assoc. 21, 677-684
MERIC, S. M., G. CHILD u. R. J. HIGGINS (1986):
Necrotizing vasculitis of the spinal pachyleptomeningeal arteries in three Bernese mountain dog littermates.
J. Am. Anim. Hosp. Assoc. 22, 459-465
MESTECKY, J., M. W. RUSSEL, S. JACKSON u. T. A. BROWN (1986):
The human IgA system: A reassessment.
Clin. Immunol. Immunopathol. 40, 105-114
MITTL, P. R. E., J. P. PRIESTLE, D. A. COX, G. MC MASTER, N. CERLETTI u. M. G.
GRÜTTER (1996):
The crystal structure of TGF-β3 and comparison to TGF-β2: Implications for receptor bindings.
Protein Sci. 5, 1261-1271
MIYAZANO, K., H. ICHIJO u. C. H. HELDIN (1993):
Transforming growth factor-β: Latent forms, binding proteins and receptors.
Growth Factors 8, 11-22
MIYAZANO, K., P. TEN DIJKE u. C. H. HELDIN (2000):
TGF-beta signaling by Smad proteins.
Adv. Immunol. 75, 115-157
MOREN, A., S. ITOH, A. MOUSTAKAS, P. TEN DIJKE u. C. H. HELDIN (2000):
Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad 4.
Oncogene 19, 4396-4404
MOSES, H. L., E. L. BRANUM, J. A. PROPER u. R. A. ROBINSON (1981):
Transforming growth factor production by chemically transformed cells.
Cancer Res. 41, 2842-2848
MOSES, H. L., R. F. TUCKER, E. B. LEOF, R. J. COFFEY JR., J. HALPER u. G. D.
SHIPLEY (1985):
Type β Transforming growth factor is a growth stimulator and a growth inhibitor.
in: J. FERAMISCO, B. OZANNE u. B. STILES (Hrsg.): Growth factors and transformation.
Cancer cells 3.
Cold Spring Harbor Press, New York, S. 65-71
NAKACHE, M., E. L. BERG, P. R. STREETER u. E. C. BUTCHER (1989):
The mucosal vascular addressin is a tissue-specific endothelial cell adhesion molecule for circulating lymphocytes.
Nature 337, 179-181
NAVIKAS; V., u. H. LINK (1996):
Review: cytokines and the pathogenesis of multiple sclerosis.
J. Neurosci. Res. 45, 322-333
O’DONOGHUE, D. J., F. JEWKES, R. J. POSTLETHWAITE u. F. W. BALLARDIE (1992):
Autoimmunity to glomerular antigens in Henoch-Schoenlein nephritis.
Clin. Sci. 83, 281-287 OELLERICH, M. (1984):
Enzyme-immunoassay: A review.
J. Clin. Chem. Clin. Biochem. 22, 895-904
OKUMURA, K., M. H. JULIUS, T. TSU, L. A. HERZENBERG u. L. A. HERZENBERG (1976):
Demonstration that IgG memory is carried by IgG-bearing cells.
Eur. J. Immunol. 6, 467-472
OSSEGE, L. M., B. VOSS, T. WIETHEGE, E. SINDERN u. J.-P. MALIN (1994):
Detection of Transforming growth factor beta 1 mRNS in cerebrospinal fluid cells of patients with meningitis by non-radioactive in situ hybridization.
J. Neurol. 242, 14-19
OSSEGE, L. M., E. SINDERN, B. VOSS u. J.-P. MALIN (1996):
Expression of tumour necrosis factor-α and Transforming growth factor-β1 in cerebrospinal fluid cells in meningitis.
J. Neurol. Sci. 144, 1-13
PADGETT, R. W., P. DAS u. S. KRISHNA (1998):
TGF-β signaling, Smads, and tumour suppressors.
Bioessays 20, 382-390
PARDALI, E., X. U. XIE, P. TSAPOGAS, S. ITOH, K. ARVANITIDIS, C. H. HELDIN, P. TEN DUKE, T. GRUNDSTROM u. P. SIDERAS (2000):
Smad and ALM proteins synergistically confer Transforming growth factor beta 1 responsiveness to human germ-line IgA genes.
J. Biol. Chem. 275, 3552-3560
PFISTER, H. W., K. FREI, B. OTTNAD, U. KOEDEL, A. TOMASZ u. A. FONTANA (1992):
Transforming growth factor beta inhibits cerebrovascular changes and brain edema formation in the tumour necrosis factor independent early phase of experimental pneumoccocal meningitis.
J. Exp. Med. 176, 265-268
PIETRA, B. A., J. De Inocencio, E. H. GIANNINI u. R. HIRSCH (1994):
TCR Vbeta family repertoire and T cell activation markers in Kawasaki disease.
J. Immunol. 153, 1881-1888
PIRCHER, R., P. JULLIEN u. D. A. LAWRENCE (1986):
Beta-Transforming growth factor is stored in human blood platelets as a latent high molecular weight complex.
Biochem. Biophys. Res. Comm. 136, 30-37 PONCELET, L., u. M. BALLIGAND (1993):
Steroid responsive meningitis in three Boxer dogs.
Vet. Rec. 132, 361-362
PORSTMANN, T., u. B. PORSTMANN (1991):
Enzymimmunoassay.
in: H. FRIEMEL (Hrsg.): Immunologische Arbeitsmethoden.
Verlag Fischer, Jena, S. 135-179 PRESTHUS, J (1991):
A septic suppurative meningitis in Bernese mountain dogs.
The Europ. J. Comp. Anim. Pract. 1, 24-28
RABBITTS, T. H., A. FORSTER, W. DUNNICK u. D. L. BENTLEY (1980):
The role of gene deletion in the immunoglobulin heavy chain switch.
Nature 283, 351-356
REYNOLDS, H. Y., u. J. S. JOHNSON (1970):
Quantitation of canine immunoglobulins.
J. Immunol. 105, 698-703
RITS, M. (1989):
IgA immune complexes are efficient activators of the alternative pathway of complement:
Studies in a homologous rat system.
Leiden, Univ., Diss.
ROBERTS, A. B., M. A. ANZANO, L. C. LAMB, J. M. SMITH u. M. B. SPORN (1981):
New class of Transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues.
Proc. Natl. Acad. Sci. (USA) 78, 5339-5343 ROBERTS, A. B., u. M. B. SPORN (1990):
The Transforming growth factor-βs.
in: M. B. SPORN u. A. B. ROBERTS (Hrsg.): Handbook of experimental pharmacology:
Peptide growth factors and their receptors.
Verlag Springer, New York, S. 419-472
ROWLEY, A. H., F. GONZALEZ-CRUSSI u. S. T. SHULMAN (1988):
Kawasaki syndrome.
Corticosteroid-responsive aseptic suppurative meningitis in three dogs.
Southwest. Vet. 35, 197-201
SAKAI, H., Y. NOMOTO u. S. ARIMORI (1979):
Decrease of IgA specific suppressor T cell activity in patients with IgA nephropathy.
Clin. Exp. Immunol. 38, 243-248
SAKAI, H., M. Endoh, Y. Tomino u. Y. NOMOTO (1982):
Increase of IgA specific helper T alpha cells in patients with IgA nephropathy.
Clin. Exp. Immunol. 50, 77-82
SCOTT-MONCRIEFF, J. C. R., P. W. SNYDER, L. T. GLICKMAN, E. L. DAVIS u. P. J.
FELSBURG (1992):
Systemic necrotizing vasculitis in nine young Beagles.
J. Am. Vet. Med. Assoc. 201, 1553-1558
SEVERINSON-GRONOWICZ, E., C. DOSS u. J. SCHRÖDER (1979):
Activation to IgG secretion by lipopolysaccharide requires several proliferative cycles.
J. Immunol. 123, 2057-2062
SHAH, M., D. M. FOREMAN u. M. W. J. FERGUSON (1995):
Neutralisation of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring.
J. Cell Sci. 108, 985-1002
SIEKEVITZ, M., C. KOCKS, K. RAJEWSKY u. R. DILDROP (1987):
Analysis of somatic mutation and class switching in naive and memory B cells generating adoptive primary and secondary responses.
Cell 48, 757-770
SNYDER, P. W., E. A. KAZACOS, J. C. SCOTT-MONCRIEFF, H. HOGENESCH, W. W.
CARLTON, L. T. GLICKMAN u. P. J. FELSBURG (1995):
Pathologic features of naturally occurring juvenile polyarteritis in Beagle dogs.
Vet. Pathol. 32, 337-345
SPENCER, A., u. P. Greaves (1987):
Periarteritis in a Beagle colony.
J. Comp. 97, 121-128
SPRENGER, H., A. ROSLER, P. TONN, H. J. BRAUNE, G. HUFFMANN u. D. GEMSA (1996):
Chemokines in the cerebrospinal fluid of patients with meningitis.
Clin. Immunol. Immunopathol. 80, 155-161
STEJSKAL, V., N. HAVU u. T. MALMFORS (1982):
Necrotizing vasculitis as an immunological complication in toxicity study.
Arch. Toxicol. Suppl. 5, 283-286 TIPOLD, A. (1994):
Klinische und immunpathologische Studien zur Meningoenzephalomyelitis beim Hund mit besonderer Berücksichtigung der steril eitrigen Meningitis- Arteriitis.
Bern, Univ., Habil.-Schr.
TIPOLD, A. (1995):
Diagnosis of inflammatory and infectious diseases of the central nervous system in dogs: A retrospective study.
J. Vet. Int. Med. 9, 304-314
TIPOLD, A. (1997):
Entzündungen im Zentralnervensystem.
Verlag Enke, Stuttgart, S. 17-29 TIPOLD, A. (1999):
Wetlab cerebrospinal fluid and cytology.
in: Proceedings of the 13th annual congress of the ESVN on neuropharmacology.
Maastricht 1999, Kongr. ber., S. 72 TIPOLD, A. (2000):
Steroid responsive meningitis-arteriitis in dogs.
in: J. D. BONAGURA u. R. W. KIRK (Hrsg.): Kirk’s current veterinary therapie XIII.
Small animal practice.
Verlag Saunders Company, Philadelphia, Pennsylvania, Bd. 13, S. 978-981 TIPOLD, A., u. A. JAGGY (1994):
Steroid responsive meningitis-arteritis in dogs: Long-term study of 32 cases.
J. Small Anim. Pract. 35, 311-316
TIPOLD, A., u. M. E. GRIOT-WENK (2000):
Prophylaxe und Therapie von immunologischen Störungen.
in: T. W. JUNGI (Hrsg.): Klinische Veterinärimmunologie.
Verlag Enke, Stuttgart, S. 135-142
TIPOLD, A., H. PFISTER u. M. VANDEVELDE (1993):
Determination of the IgG index for the detection of intrathecal immunoglobulin synthesis in dogs using an ELISA.
Res. Vet. Sci. 54, 40-44
TIPOLD, A., H. PFISTER, A. ZURBRIGGEN u. M. VANDEVELDE (1994):
Intrathecal synthesis of major immunoglobulin classes in inflammatory diseases of canine CNS.
Vet. Immunol. Immunopathol. 42, 149-159
TIPOLD, A., M. VANDEVELDE u. A. ZURBRIGGEN (1995):
Neuroimmunological studies in steroid-responsive meningitis-arteriitis in dogs.
Res. Vet. Sci. 58, 103-108
TIPOLD, A., H. PFISTER u. T. W. JUNGI (1996a):
IgA-Mangel beim Hund.
Der praktische Tierarzt 3, S. 181-187
TIPOLD, A., R. SOMBERG u. P. FELSBURG (1996b):
Gibt es einen Superantigeneinfluß bei steril eitriger Meningitis-Arteriitis des Hundes?
Tierärztl. Prax. 24, 514-518
TIPOLD, A., P. MOORE, A. ZURBRIGGEN u. M. VANDEVELDE (1999):
Lymphocyte subset distribution in steroid responsive meningitis-arteriitis in comparison to different canine encephalitides.
J. Vet. Med. A 46, 75-85 TIZARD, I. (1996):
Veterinary immunology. An introduction.
5. Aufl. Verlag Saunders Company, Philadelphia, London, S. 257 TIZARD, I. (2000):
Veterinary immunology. An introduction.
6. Aufl. Verlag Saunders Company, Philadelphia, London, S. 136, 139-145, 225-230 TOMASI, T. B. Jr. (1972):
Secretory immunoglobulins.
New England Journals of Medicine 287, 500-506
TSAI, S. C., B. A. SUMMERS u. M. J. G. APPEL (1982):
Interferon in cerebrospinal fluid. A marker for viral persistence in canine distemper encephalomyelitis.
Archives of Virology 72, 257-265
TYOR, W. R., T. R. MOENCH u. D. E. GRIFFIN (1989):
Characterization of the local and systemic B cell response of normal and athymic nude mice with Sindbis virus encephalitis.
J. Neuroimmunol. 24, 207-215
ULLOA, L., J. DOODY u. J. MASSAGUE (1999):
Inhibition of Transforming growth factor-beta / Smad signalling by the interferon-gamma / STAT pathway.
Nature 397, 710-713
UNDERDOWN, B. J., u. J. M. SCHIFF (1986):
Immunoglobulin A: Strategic defence initiative at the mucosal surface.
Annu. Rev. Immunol. 4, 389-417
VAERMAN, J. P. u. J. F. HEREMANS (1970):
Origin and molecular size of immunoglobulin A in the mesenteric lymph of the dog.
Immunology 18, 27-38
VANDEVELDE, M., u. J. S. SPANO (1977):
Cerebrospinal fluid cytology in canine neurologic disease.
Cerebrospinal fluid cytology in canine neurologic disease.